Original Research

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN

Hypoxia 2017, 5:45-59

Published Date: 23 May 2017